SUBCELLULAR LOCALIZATION
| extracellular
|
| intracellular
|
| intracellular,cytoplasm,organelle,lumen
|
| intracellular,cytoplasm,organelle,membrane
|
| intracellular,cytoplasm,organelle,endosome
|
| intracellular,cytoplasm,organelle,lysosome
|
text
| IFI30 and CTSS colocalized within lysosomes of B cells  |
basic FUNCTION
| cysteine protease having a central role in remodeling the extracellular matrix and implicated in the etiology of cardiovascular disease |
|
cysteine endoprotease specifically involved in MHCII-associated chain processing and peptide loading |
|
lysosomal cysteine proteinase may be participating in the degradation of antigenic proteins to peptides for presentation on MHC class II molecules |
|
playing a specific role in the generation of antigenic peptides |
|
playing a functional role in angiogenesis and neoplastic progression |
|
having a potential role to promote preadipocyte differentiation |
|
may promote adipogenesis, at least in part, by degrading fibronectin in the early steps of differentiation, and having a possible contribution to fat mass expansion in obesity |
|
may play a role in determining the Apo-A1 and HDL-C profiles and may thus influence reverse cholesterol transport |
|
may play a role in the activation of an adoptive immune response  |
|
with CTSL, and CTSK, implicated in atherogenesis  |
|
importance of CTSB, CTSS and Cystatins in immunomodulation  |
|
in lysosomes is essential for mitophagy processing in macrophages  |
|
CTSB, CTSK, CTSL1, CTSS may be putative leptin activity regulators in white adipose tissue (WAT)  |
|
has a much lower binding affinity and catalytic rate for collagen I and cleaves only at the telopeptide regions of the molecule, regions that are increasingly exposed after hydrolysis by CTSK  |
|
may participate in basement membrane (BM) proteolysis, in addition to already identified proteases  |
|
physiologic mechanism that regulates CTSS and has implications for fine tuning MHC class II-restricted Ag processing and for the development of CTSS inhibitors, which are under investigation for the treatment of autoimmune disease  |
|
may contribute significantly to cartilage degradation and may thus be considered a potential drug target in joint diseases  |
|
CTSS secreted by microglia during the dark-phase decreases the spine density of the cortical neurons by modifying the perisynaptic environment, leading to downscaling of the synaptic strength during the subsequent light-phase  |
|
peripheral pivotal role of CTSS in the development of neuropathic pain through the antigen-specific activation of CD4(+) T-cells  |
|
tumor-promoting role of autophagy in tumor-associated macrophages (TAMs), suggesting CTSS could be a potential target for cancer therapy  |
|
cysteine protease that controls adipocyte differentiation and has been implicated in vascular and metabolic complications of obesity  |
|
CTSZ is the compensatory protease that regulates the acquired tumor-promoting functions of lesions deficient in both CTSB and CTSS  |